Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

Published:2010-11-16 Issue:6 Volume:12 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Liu Yanying,Mu Rong,Wang Shiyao,Long Li,Liu Xia,Li Ru,Sun Jian,Guo Jianping,Zhang Xiaoping,Guo Jing,Yu Ping,Li Chunlei,Liu Xiangyuan,Huang Zhenyu,Wang Dapeng,Li Hu,Gu Zhifeng,Liu Bing,Li Zhanguo

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/ar3187.pdf

Reference45 articles.

1. Van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, van Laar JM: Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann Rheum Dis. 2005, 64: 537-543. 10.1136/ard.2004.024927.

2. Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT: Rituximab therapy reduces activated B cells both in the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response. Arthritis Res Ther. 2009, 11: R131-10.1186/ar2798.

3. Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register: Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006, 54: 1786-1794. 10.1002/art.21830.

4. Listing J, Strangfeld A, Rau R, Kekow J, Gromnica-Ihle E, Klopsch T, Demary W, Burmester GR, Zink A: Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low- results from RABBIT, the German biologics register. Arthritis Res Ther. 2006, 8: R66-10.1186/ar1933.

5. Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003, 171: 6173-6177.

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications;Inflammation and Regeneration;2024-07-19

2. The Role of Mesenchymal Stromal Cells in the Treatment of Rheumatoid Arthritis;Cells;2024-05-25

3. IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis;International Journal of Molecular Sciences;2024-04-18

4. Human ovarian tissue xenotransplantation in 3D-printed tissue trapper basket integrated with human umbilical cord mesenchymal stem cells;2024-03-06

5. Gingival mesenchymal stem cells derived from patients with rheumatoid arthritis treats experimental arthritis;2023-11-07